- Home
- EXEL vs IEX Comparison
EXEL vs IEX Comparison
Compare EXEL & IEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- IEX
- Stock Information
- Founded
- EXEL 1994
- IEX 1987
- Country
- EXEL United States
- IEX United States
- Employees
- EXEL N/A
- IEX N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- IEX Fluid Controls
- Sector
- EXEL Health Care
- IEX Industrials
- Exchange
- EXEL Nasdaq
- IEX Nasdaq
- Market Cap
- EXEL 10.4B
- IEX 12.4B
- IPO Year
- EXEL 2000
- IEX 1991
- Fundamental
- Price
- EXEL $37.88
- IEX $162.85
- Analyst Decision
- EXEL Buy
- IEX Buy
- Analyst Count
- EXEL 22
- IEX 6
- Target Price
- EXEL $44.00
- IEX $208.83
- AVG Volume (30 Days)
- EXEL 2.4M
- IEX 653.8K
- Earning Date
- EXEL 10-28-2025
- IEX 10-28-2025
- Dividend Yield
- EXEL N/A
- IEX 1.71%
- EPS Growth
- EXEL 81.76
- IEX N/A
- EPS
- EXEL 2.08
- IEX 6.18
- Revenue
- EXEL $2,230,005,000.00
- IEX $3,340,800,000.00
- Revenue This Year
- EXEL $9.10
- IEX $6.19
- Revenue Next Year
- EXEL $12.47
- IEX $4.00
- P/E Ratio
- EXEL $18.54
- IEX $26.82
- Revenue Growth
- EXEL 10.73
- IEX 4.73
- 52 Week Low
- EXEL $25.17
- IEX $153.36
- 52 Week High
- EXEL $49.62
- IEX $238.22
- Technical
- Relative Strength Index (RSI)
- EXEL 38.92
- IEX 45.13
- Support Level
- EXEL $38.35
- IEX $164.25
- Resistance Level
- EXEL $41.44
- IEX $168.29
- Average True Range (ATR)
- EXEL 0.97
- IEX 2.67
- MACD
- EXEL -0.26
- IEX 0.46
- Stochastic Oscillator
- EXEL 2.48
- IEX 40.02
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About IEX IDEX Corporation
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2024.